Pharma Journalist
  • facebook
  • twitter
  • google_plus
  • Email
Pharma Journalist

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

CAPVAXIVE Shows Strong Immune Response in At-Risk Children and Teens

Read more

Kashiv BioSciences and CRISTÁLIA Sign Licensing and Supply Deal for Omalizumab Biosimilar in Latin America

Read more

Scipher Medicine and Maxymune Therapeutics Partner to Speed Autoimmune and Inflammatory Disease Target Discovery

Read more

Kytopen Partners with BlueWhale Bio to Transform Cell Therapy Manufacturing

Read more

FDA Launches Major Crackdown on Deceptive Drug Advertising

Read more

FDA Approves INLEXZO (Gemcitabine Intravesical System), Poised to Transform Treatment of Certain Bladder Cancers

Read more

Teva’s Emrusolmin Receives FDA Fast Track Designation for Multiple System Atrophy Treatment

Read more

Novartis to Acquire Tourmaline Bio, Boosting Cardiovascular Pipeline with Pacibekitug for ASCVD Treatment

Read more

Health Canada Approves Bylvay for Treating Cholestatic Pruritus in Alagille Syndrome Patients

Read more

Servier Acquires Promising Fragile X Syndrome Treatment, Key Genetic Cause of Autism

Read more

Posts pagination

Previous Page 1 of 936 … Page 60 of 936 … Page 936 of 936 Next
  • About
  • Advertise
  • Subscribe
  • Contact
View Desktop Version